Business (Health)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Deals
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Deals
Karo Expands Intimate Health Offering With Bayer's Proctosedyl
Sweden's Karo has struck its second deal in six months bringing in the Proctosedyl hemorrhoid brand from Bayer.
C&D Investors, Analysts Not On Same Page
Share price’s recent ride doesn’t track with analysts’ regard for C&D’s results and outlook.
UK’s Dexcel Pharma Snaps Up Eight OTC Brands From Teva
Dexcel Pharma has acquired eight OTC brands from Teva, including Bisodol Indigestion Relief Tablets, erectile dysfunction treatment Liberize and Yeast Vite supplements. Teva told HBW Insight it remains committed to the consumer health market despite a number of recent brand divestments.
Strategy
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Business Strategies
Stada Grows Twice As Fast As CHC Market In 2023
Stada's local brand focus helped it deliver Consumer Healthcare sales growth of 16% in 2023 ensuring the German firm significantly outpaced the overall market growth rate of 7%.
Valisure Will Continue As 'Inconvenient' Reminder For Change To US Drug Quality ‘Status Quo’
“I think the symptoms of the core disease of quality is not having an independent layer or just not being able to invest more in quality or whatever the other root causes of addressing these quality issues,” says analytical lab president David Light.
EU Firms To Pre-Approve Green Claims Or Face Minimum 4% Annual Turnover Fine
Exclusion from procurement processes, confiscation of revenues, and a fine of at least 4% of annual turnover are some of the penalties the European Parliament is considering for greenwashing as part of its position on the EU Green Claims Directive.
Sales & Earnings
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Sales & Earnings
Stada Grows Twice As Fast As CHC Market In 2023
Stada's local brand focus helped it deliver Consumer Healthcare sales growth of 16% in 2023 ensuring the German firm significantly outpaced the overall market growth rate of 7%.
Bayer To Hold On To Consumer Health While It Deals With More Pressing Issues
With Bayer "badly broken in four places," now is not the right time to consider offloading its Consumer Health business, according to group CEO Bill Anderson. Bayer must focus its full attention for the next few years on addressing challenges which include mounting debt and costly litigation before a change to the company's structure can be considered.
‘The Problem Is In-Store’: Kenvue CEO Mongon Lays Out Plan To Kickstart Skin Health & Beauty
The J&J spinout and Neutrogena and Aveeno owner says the challenge facing its Skin Health and Beauty business is not about brand equity or online performance as much as in-store in the US, where it has underperformed. CEO Thibaut Mongon outlined planned investments, expected to drive growth acceleration in Kenvue’s fiscal 2024 second half, at the CAGNY 2024 conference.
Litigation
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Health & Legal Issues
Cue The Class Actions! Plaintiffs React To Valisure’s Benzene Findings In Acne Drug Products
J&J, Target and Walgreens face class action complaints in California federal courts for economic harms caused by their sale of benzoyl peroxide-containing acne treatments, following Valisure’s 5 March citizen petition to the US FDA on findings of high levels of benzene in such products.
US FDA Should Reload Field Force To Target OTC Adulteration, Former Chief Counsel Hutt Says
Habitually noncompliant companies are laughing at FDA, Peter Barton Hutt says.
FTC Might Need More Illumination On Proposed Rule For Online Consumer Product Reviews
BBB National Programs found FTC’s proposed Trade Regulation Rule on the Use of Consumer Reviews and Testimonials largely effective with some certainty on whether product reviews or customer testimonials are violations of its false advertising standards. But it =expects some clarifications may come in final rule.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.